The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy

被引:135
作者
Sifuentes-Franco, Sonia [1 ]
Paul Pacheco-Moises, Fermin [2 ]
Daniel Rodriguez-Carrizalez, Adolfo [1 ]
Guillermina Miranda-Diaz, Alejandra [1 ]
机构
[1] Univ Guadalajara, Univ Hlth Sci Ctr, Dept Physiol, Inst Expt & Clin Therapeut, Guadalajara, Jalisco, Mexico
[2] Univ Guadalajara, Univ Ctr Exact & Engn Sci, Dept Chem, Guadalajara, Jalisco, Mexico
关键词
ENDOPLASMIC-RETICULUM STRESS; GLYCATION END-PRODUCTS; CYTOCHROME-C RELEASE; ALPHA-LIPOIC ACID; NITRIC-OXIDE; ALDOSE REDUCTASE; ANTIOXIDANT TREATMENT; PERIPHERAL NEUROPATHY; THERAPEUTIC TARGETS; ROSEMARY EXTRACTS;
D O I
10.1155/2017/1673081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic polyneuropathy (DPN) is the most frequent and prevalent chronic complication of diabetes mellitus (DM). The state of persistent hyperglycemia leads to an increase in the production of cytosolic and mitochondrial reactive oxygen species (ROS) and favors deregulation of the antioxidant defenses that are capable of activating diverse metabolic pathways which trigger the presence of nitro-oxidative stress (NOS) and endoplasmic reticulum stress. Hyperglycemia provokes the appearance of micro-and macrovascular complications and favors oxidative damage to the macromolecules (lipids, carbohydrates, and proteins) with an increase in products that damage the DNA. Hyperglycemia produces mitochondrial dysfunction with deregulation between mitochondrial fission/fusion and regulatory factors. Mitochondrial fission appears early in diabetic neuropathy with the ability to facilitate mitochondrial fragmentation. Autophagy is a catabolic process induced by oxidative stress that involves the formation of vesicles by the lysosomes. Autophagy protects cells from diverse stress factors and routine deterioration. Clarification of the mechanisms involved in the appearance of complications in DM will facilitate the selection of specific therapeutic options based on the mechanisms involved in the metabolic pathways affected. Nowadays, the antioxidant agents consumed exogenously form an adjuvant therapeutic alternative in chronic degenerative metabolic diseases, such as DM.
引用
收藏
页数:15
相关论文
共 150 条
[1]   Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study [J].
Albers, James W. ;
Herman, William H. ;
Pop-Busui, Rodica ;
Feldman, Eva L. ;
Martin, Catherine L. ;
Cleary, Patricia A. ;
Waberski, Barbara H. ;
Lachin, John M. .
DIABETES CARE, 2010, 33 (05) :1090-1096
[2]  
Asano Goro, 2003, Journal of Nippon Medical School, V70, P384, DOI 10.1272/jnms.70.384
[3]   Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy [J].
Askwith, Trevor ;
Zeng, Wei ;
Eggo, Margaret C. ;
Stevens, Martin J. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 297 (03) :E620-E628
[4]   Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses [J].
Ayepola, Omolola R. ;
Chegou, Novel N. ;
Brooks, Nicole L. ;
Oguntibeju, Oluwafemi O. .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 13
[5]   Molecular Intricacies and the Role of ER Stress in Diabetes [J].
Balasubramanyam, Muthuswamy ;
Singh, Lalit P. ;
Rangasamy, Sampathkumar .
EXPERIMENTAL DIABETES RESEARCH, 2012,
[6]   Oxidative Stress as an Underlying Contributor in the Development of Chronic Complications in Diabetes Mellitus [J].
Bandeira, Suziy de M. ;
da Fonseca, Lucas Jose S. ;
Guedes, Glaucevane da S. ;
Rabelo, Luiza A. ;
Goulart, Marilia O. F. ;
Vasconcelos, Sandra Mary L. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (02) :3265-3284
[7]   Structure of a repair enzyme interrogating undamaged DNA elucidates recognition of damaged DNA [J].
Banerjee, A ;
Yang, W ;
Karplus, M ;
Verdine, GL .
NATURE, 2005, 434 (7033) :612-618
[8]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[9]   Diabetic neuropathies - A statement by the American Diabetes Association [J].
Boulton, AJM ;
Vinik, AI ;
Arezzo, JC ;
Bril, V ;
Feldman, EL ;
Freeman, R ;
Malik, RA ;
Maser, RE ;
Sosenko, JM ;
Ziegler, D .
DIABETES CARE, 2005, 28 (04) :956-962
[10]  
Boykin JV, 2006, WOUNDS, V18, P2